HTG Molecular Diagnostics Short Interest Ratio and Short Volume

Short interest is the volume of HTG Molecular Diagnostics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 95,400 shares of HTGM short. 1.73% of HTG Molecular Diagnostics' shares are currently sold short. View details.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HTG Molecular Diagnostics currently has a short interest ratio of 1.0.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.73% of HTG Molecular Diagnostics' floating shares are currently sold short.

HTG Molecular Diagnostics saw a increase in short interest in March. As of March 31st, there was short interest totaling 95,400 shares, an increase of 57.2% from the previous total of 60,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

HTG Molecular Diagnostics currently has issued a total of 6,214,000 shares. Some of HTG Molecular Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HTG Molecular Diagnostics currently has a public float of 5,500,000 shares.

1.73% of HTG Molecular Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "analytical instruments" compare to HTG Molecular Diagnostics: Illumina, Inc. (2.16%), Agilent Technologies, Inc. (0.88%), Mettler-Toledo International Inc. (1.89%), 10x Genomics, Inc. (2.44%), Bio-Rad Laboratories, Inc. (2.54%), Waters Co. (2.12%), Avantor, Inc. (3.24%), PerkinElmer, Inc. (0.00%), Bruker Co. (1.82%), and Coherent, Inc. (6.14%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling HTGM is an investing strategy that aims to generate trading profit from HTG Molecular Diagnostics as its price is falling. HTG Molecular Diagnostics' stock is trading down $0.28 today. To short HTG Molecular Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that HTG Molecular Diagnostics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for HTG Molecular Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HTGM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HTGM, twice per month. The most recent reporting period available is March, 31 2021.